Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A once prominent biotechnology investor was handed four years in prison on Thursday after pleading guilty to stock manipulation, the second time he has run afoul of U.S. securities laws. David Blech, 57, pleaded guilty in May 2012 to securities fraud charges stemming from improper trades in biopharmaceutical companies Pluristem Therapeutics Inc and Intellect Neurosciences Inc. Blech pleaded guilty in 1998 to similar charges of illegal trading, getting five years of probation rather than jail time. On Thursday, U.S. District Judge Colleen McMahon in Manhattan expressed anger at his repeat offense and rejected his lawyer’s request for leniency. “No, not this time,” McMahon said. “No mercy. This time, punishment.”
Help employers find you! Check out all the jobs and post your resume.
